Mevion Medical Systems Release: Medstar Georgetown To Install MEVION S250 Proton Therapy System To Treat Adult And Pediatric Cancer Patients

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems, Inc., announced today that MedStar Georgetown University Hospital has received final approval to begin construction of the first proton therapy center in Washington, D.C. at its Lombardi Comprehensive Cancer Center. Georgetown Lombardi is the only cancer center in the D.C. area to earn the National Cancer Institute (NCI) designation as a comprehensive cancer center. The MEVION S250, the world’s smallest single room proton therapy system, is a revolutionary device that delivers the same precise, non-invasive treatment advantages and capabilities of larger, more expensive proton therapy systems but with a significantly reduced footprint, improved reliability, more efficient patient access, and dramatically lower implementation and operational costs.

Hey, check out all the research scientist jobs. Post your resume today!